Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aptuit | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Aptuit

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aptuit, Inc. has appointed Dr. Michael J. Butler president, scientific operations of its drug development services. He will assume responsibility for all of Aptuit’s scientific operations, which span API development, preclinical technologies, analytics, and pharmaceutics, consisting of more than 875 scientists and technical staff in Kansas City, MO and Edinburgh, Scotland.

Dr. Butler has 20 years of experience in pharmaceutical drug development. He most recently served as group vice president, early clinical and bioanalytical, and senior vice president, marketing and business development at MDS Pharma Services, where he led multi-site operations and oversaw strategic alignment of the company’s global operations.

Prior to MDS, Dr. Butler was the former group director, business development and director, pharmaceutical business development for Huntingdon Life Sciences. He was also the director, customer service at Lockheed Environmental Systems and Technology Co. and head of department, Corning Enseco, Inc. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics